Načítá se...

Cabozantinib and apixaban: an hitherto unreported interaction

The use of direct oral anticoagulant in cancer patients is an emerging issue, which seems to be an alternative to low molecular weight heparin. Every year several new drugs are approved as anticancer treatment with possible drug-drug interaction with other drugs such as oral anticoagulant. We descri...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Exp Hematol Oncol
Hlavní autoři: Santini, Daniele, Citarella, Fabrizio, Vincenzi, Bruno, Russano, Marco, Tonini, Giuseppe, Stellato, Marco
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2019
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6737677/
https://ncbi.nlm.nih.gov/pubmed/31528502
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40164-019-0146-9
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!